State filing guide
CLIA waiver application and requirements in Alaska.
Ask about my application — no payment todayAlaska's published CLIA application procedure uses Form CMS-116.
Sources checked 2026-11-12 · next source check due 2026-12-12
Federal application procedure
These findings describe the linked sources. They do not establish that your facility qualifies for an exemption or that its application is ready. Facility type, ownership, personnel, locations and exact test systems can change the requirements.
Have your Alaska CLIA waiver application prepared for you — US$195
We check each test you plan to run, prepare your Alaska CMS-116 ready to sign, and give you signature and filing instructions. If our check shows that you do not need a certificate, or we cannot take your case, we refund the US$195 in full. Leave your email and we will send you the details and the payment link.
What the official sources say
- For an ordinary single-site waived-only physician office, the published state CLIA procedure lists CMS-116 and the CMS fee, with no additional state laboratory application, license or fee identified. An express statewide no-license/no-fee statement was not verified. Any additional state fee depends on the facility and professional scope; confirm unusual arrangements before filing.
- Alaska Department of Health, State Laboratories / CLIA: initial CMS-116 by email to hss.dph.lab.clia@alaska.gov. General inquiries: doh.clia.info@alaska.gov. CMS directory contact: CLIA-HSSLab@alaska.gov; 5455 Dr. Martin Luther King Jr. Ave., Anchorage, AK 99507; fax 907-334-2161. The state procedure expressly selects hss.dph.lab.clia@alaska.gov for completed CMS-116 applications. Use the state application email for initial filing; confirm any alternative address and resolve the contact discrepancy with the CLIA program. Confirm an accepted initial-filing method with the program before using its directory postal or fax contacts. A human confirms current signature requirements, obtains client authorization, sends the signed packet and retains delivery evidence.
- Form CMS-116 (04/2026), OMB expiration 04/30/2029, mandatory revised edition from November 9, 2026. For initial Certificate of Waiver, leave the initial CLIA number blank, select Waiver, complete sections 1-6 and 9-10, identify exact test systems and annual volumes, and obtain the laboratory director, owner or authorized representative signature. Include every applicable application page, including the signature on printed page 6 (physical PDF sheet 7). Record a monitored business email for mandatory electronic CMS communications. No payment with the application; retain any state-specific enclosures listed separately.
- If blood lead is performed, arrange SOE reporting enrollment and a validated HL7 or CSV/SFTP workflow. Report all Alaska-resident capillary and venous results within 28 days; providers report results at or above the CDC blood lead reference value within 7 days. The state reporting page uses the current CDC blood lead reference value for urgent provider reporting. Paper is not acceptable at 10 or more tests per week. Separate private analyzer authorization/registration was not verified. Blood lead requires case-specific review of enrollment, exact waived use, confirmatory referral and urgent reporting before a written quote. State-laboratory referral approval, if required, is not a private analyzer operating permit. Blood lead is confirmed case by case with the reviewer and quoted separately in writing after review.
Fees and timing
Federal Certificate of Waiver: $248 per two-year certificate, paid through Pay.gov after the electronic CMS fee coupon and CLIA ID. No payment with CMS-116 and no paper checks. Government fees are separate from WaivedLab preparation-service fees. Begin testing only after receiving the certificate; no processing or approval date is promised. For an ordinary single-site waived-only physician office, the published state CLIA procedure lists CMS-116 and the CMS fee, with no additional state laboratory application, license or fee identified. An express statewide no-license/no-fee statement was not verified. Any additional state fee depends on the facility and professional scope; confirm unusual arrangements before filing.
Check my test menuWhat still needs confirmation for your facility
- 1Confirm an initial, fixed, single-site office testing only its own patients with exact unmodified waived systems; review other facility types, outside referrals, mobile/multisite, PPM and non-waived testing separately.
- 2Before filing, review and sign the completed packet, confirm the accepted submission method and authorize submission; retain delivery evidence. Resolve any additional requirements for your facility before filing.
- 3Will this site perform on-site blood lead testing? Confirm reporting enrollment, deadlines, exact waived use, venous confirmation/referral and any personnel, analyzer or reimbursement duties case by case with the reviewer before including blood lead.
Frequently asked questions
What filing route does the cited Alaska guidance describe?
Alaska's published CLIA application procedure uses Form CMS-116.
Which requirements are named in the cited Alaska materials?
For an ordinary single-site waived-only physician office, the published state CLIA procedure lists CMS-116 and the CMS fee, with no additional state laboratory application, license or fee identified. An express statewide no-license/no-fee statement was not verified. Any additional state fee depends on the facility and professional scope; confirm unusual arrangements before filing. Alaska Department of Health, State Laboratories / CLIA: initial CMS-116 by email to hss.dph.lab.clia@alaska.gov. General inquiries: doh.clia.info@alaska.gov. CMS directory contact: CLIA-HSSLab@alaska.gov; 5455 Dr. Martin Luther King Jr. Ave., Anchorage, AK 99507; fax 907-334-2161. The state procedure expressly selects hss.dph.lab.clia@alaska.gov for completed CMS-116 applications. Use the state application email for initial filing; confirm any alternative address and resolve the contact discrepancy with the CLIA program. Confirm an accepted initial-filing method with the program before using its directory postal or fax contacts. A human confirms current signature requirements, obtains client authorization, sends the signed packet and retains delivery evidence. Form CMS-116 (04/2026), OMB expiration 04/30/2029, mandatory revised edition from November 9, 2026. For initial Certificate of Waiver, leave the initial CLIA number blank, select Waiver, complete sections 1-6 and 9-10, identify exact test systems and annual volumes, and obtain the laboratory director, owner or authorized representative signature. Include every applicable application page, including the signature on printed page 6 (physical PDF sheet 7). Record a monitored business email for mandatory electronic CMS communications. No payment with the application; retain any state-specific enclosures listed separately. If blood lead is performed, arrange SOE reporting enrollment and a validated HL7 or CSV/SFTP workflow. Report all Alaska-resident capillary and venous results within 28 days; providers report results at or above the CDC blood lead reference value within 7 days. The state reporting page uses the current CDC blood lead reference value for urgent provider reporting. Paper is not acceptable at 10 or more tests per week. Separate private analyzer authorization/registration was not verified. Blood lead requires case-specific review of enrollment, exact waived use, confirmatory referral and urgent reporting before a written quote. State-laboratory referral approval, if required, is not a private analyzer operating permit. Blood lead is confirmed case by case with the reviewer and quoted separately in writing after review.
What do the sources establish about fees and timing in Alaska?
Federal Certificate of Waiver: $248 per two-year certificate, paid through Pay.gov after the electronic CMS fee coupon and CLIA ID. No payment with CMS-116 and no paper checks. Government fees are separate from WaivedLab preparation-service fees. Begin testing only after receiving the certificate; no processing or approval date is promised. For an ordinary single-site waived-only physician office, the published state CLIA procedure lists CMS-116 and the CMS fee, with no additional state laboratory application, license or fee identified. An express statewide no-license/no-fee statement was not verified. Any additional state fee depends on the facility and professional scope; confirm unusual arrangements before filing.
Does this page confirm CLIA approval or legal compliance in Alaska?
No. This is an educational prep checklist. It does not confirm approval, legal compliance, or waived status for any specific device. Verify every requirement with CMS, the FDA, and your state agency before testing.
Other jurisdictions
Each jurisdiction publishes its own terminology, forms, channel, signatures, and fees.
All 52jurisdictions →Need help with your Alaska CLIA route?
Tell us where your clinic operates and what you need to prepare or change. You can ask before you know your exact test system. We review the next facts needed before proposing any paid scope.
Request a scope inquiry — no payment today
Business inquiries only. Do not send patient information, test results, dates of birth, government identifiers, credential numbers, or documents.
From test research to your Alaska application
An analyte label does not confirm a device. The exact test system and the clinic’s state route need separate review before a filing scope or price can be confirmed.